Ovation Science (XCNQ:OVAT) Gross-Profit-to-Asset % : 103.23% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Ovation Science Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Ovation Science's annualized Gross Profit for the quarter that ended in Mar. 2024 was C$0.08 Mil. Ovation Science's average Total Assets over the quarter that ended in Mar. 2024 was C$0.08 Mil. Therefore, Ovation Science's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 103.23%.

Ovation Science Gross-Profit-to-Asset % Historical Data

The historical data trend for Ovation Science's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovation Science Gross-Profit-to-Asset % Chart

Ovation Science Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

12.44

21.52

9.35

30.86

59.34

Ovation Science Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															135.54	3.17	10.17	40.40	103.23

Competitive Comparison of Ovation Science's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Ovation Science's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ovation Science's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ovation Science's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Ovation Science's Gross-Profit-to-Asset % falls into.

Ovation Science Gross-Profit-to-Asset % Calculation

Ovation Science's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	0.054	/	( (0.105	+	0.077)	/ 2 )
	=	0.054	/	0.091
	=	59.34 %

Ovation Science's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	0.08	/	( (0.077	+	0.078)	/ 2 )
	=	0.08	/	0.0775
	=	103.23 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Ovation Science Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Ovation Science's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ovation Science (XCNQ:OVAT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ovation Science Inc (XCNQ:OVAT) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

OVATF:USA

Address

625 Howe Street, Suite 1140, Vancouver, BC, CAN, V6C 2T6

Website

https://www.ovationscience.com

Ovation Science Inc is a Canada-based company mainly engaged in the business of sub-licensing rights to use Invisicare, a patented drug delivery technology used in topical and transdermal skin products containing hemp seed oil and cannabis products. The company also holds the right to manufacture, distribute, sell, market, sub-license and promote products formulated with Invisicare and containing cannabis products including cannabinoids, hemp seed oil and any synthetic derivatives of cannabis. It also develops formulas for skin product lines including topical and transdermal creams and lotions containing hemp seed oil and cannabis.

Executives

David K. Ryan

Director

Ovation Science (XCNQ:OVAT) Headlines

No Headlines